Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Endometrium”

1,471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,471 results

Testing effectiveness (Phase 2)UnknownNCT03567655
What this trial is testing

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Asan Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT00087685
What this trial is testing

RAD001 in Recurrent Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 500
Not applicableLooking for participantsNCT05761561
What this trial is testing

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

Who this might be right for
Ovarian Cancer
Yale University 200
Testing effectiveness (Phase 2)Study completedNCT00401635
What this trial is testing

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Who this might be right for
Endometrial Cancer
National Cancer Institute, Naples 42
Testing effectiveness (Phase 2)Looking for participantsNCT05758688
What this trial is testing

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Who this might be right for
Cervical CancerUterine CancerEndometrial Cancer
Abramson Cancer Center at Penn Medicine 25
Not applicableStudy completedNCT00342446
What this trial is testing

A Follow-up Study of Women Evaluated and Treated for Infertility

Who this might be right for
Ovarian CancerBreast CancerEndometrial Cancer+2 more
National Cancer Institute (NCI) 12,193
Early research (Phase 1)Not Yet RecruitingNCT07318324
What this trial is testing

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Who this might be right for
Phase IBAvutometinibRAS Pathway+1 more
M.D. Anderson Cancer Center 31
Not applicableUnknownNCT06250010
What this trial is testing

Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

Who this might be right for
Endometrial Cancer
Regina Elena Cancer Institute 30
Early research (Phase 1)UnknownNCT01454479
What this trial is testing

A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Who this might be right for
Recurrent Endometrial Cancer
Hung-Hsueh Chou 24
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Early research (Phase 1)Looking for participantsNCT07470853
What this trial is testing

MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Who this might be right for
PROCPlatinum Resistant Ovarian CancerEndometrial Cancer
Whitehawk Therapeutics, Inc. 265
Not applicableStudy completedNCT03460483
What this trial is testing

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Who this might be right for
Endometrial AdenocarcinomaEndometrial CarcinomaLynch Syndrome+1 more
Ohio State University Comprehensive Cancer Center 1,001
Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Testing effectiveness (Phase 2)Ended earlyNCT04030429
What this trial is testing

Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
National Cheng-Kung University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00334295
What this trial is testing

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Who this might be right for
Endometrial Carcinoma
AstraZeneca 35
Not applicableStudy completedNCT04184154
What this trial is testing

Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy.

Who this might be right for
Pelvic CancerCervical Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 167
Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

LY4170156 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 495
Load More Results